NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10939	Companies
238870	Keywords
167696	Articles
128387	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 03/17/2025 at 21:20, 1 year 5 months ago

NANOBIOTIX Extends its Financial Horizon until mid-2026

License Agreement NANOBIOTIX NBTXR3 Financial Visibility Janssen
PRESS RELEASE

published on 03/17/2025 at 21:15, 1 year 5 months ago

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026
Nanobiotix renforce sa visibilité financière en amendant son accord de licence avec JNJ-1900 (NBTXR3), étendant son horizon de trésorerie jusqu’à mi-2026. Conférence le 18/03/2025

Trésorerie Accord De Licence NANOBIOTIX Visibilité Financière JNJ-1900
PRESS RELEASE

published on 03/17/2025 at 21:15, 1 year 5 months ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
Nanobiotix strengthens financial position by amending global licensing agreement for JNJ-1900 (NBTXR3), extending cash visibility to mid-2026. Details of the amendment and future potential milestone payments outlined

Financial Position Milestone Payments NANOBIOTIX JNJ-1900 Global Licensing Agreement
BRIEF

published on 03/13/2025 at 22:20, 1 year 5 months ago

Nanobiotix Reports Voting Rights and Share Capital Details

Euronext Paris Voting Rights Financial Transparency NANOBIOTIX Shares Outstanding
BRIEF

published on 03/13/2025 at 22:20, 1 year 5 months ago

Nanobiotix publie les détails de ses droits de vote et de son capital social

Euronext Paris Droit De Vote Transparence Financière Actions En Circulation NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 1 year 5 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital. Detailed breakdown of outstanding shares and voting rights presented. Company overview and contact information included

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 1 year 5 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix communique sur le nombre total d'actions et de droits de vote. Informations boursières et présentation de l'entreprise de biotechnologie

Droits De Vote Euronext Biotechnologie Actions NANOBIOTIX
BRIEF

published on 02/12/2025 at 22:20, 1 year 6 months ago

Nanobiotix : Détails sur les Droits de Vote et Actions en Janvier 2025

Euronext Paris Droits De Vote Actions Nasdaq NANOBIOTIX
BRIEF

published on 02/12/2025 at 22:20, 1 year 6 months ago

Nanobiotix: Details on Voting Rights and Shares in January 2025

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 02/12/2025 at 22:15, 1 year 6 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Communiqué mensuel de Nanobiotix sur les droits de vote et actions. Informations financières conformes à la règlementation des marchés financiers. Nanobiotix, société de biotechnologie, cotée à Euronext Paris et Nasdaq, développe des traitements innovants

Euronext Paris Biotechnologie Nasdaq NANOBIOTIX Traitements Innovants

Accesswire

Published on 09/05/2026 at 04:05, 2 days 3 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 7 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 8 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 8 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 16 hours ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/07/2026 at 07:00, 14 minutes ago

Swiss Re sees growing protection needs as risks become more complex and interconnected
Published on 09/07/2026 at 07:00, 14 minutes ago

Half-year results for 2026 show a further increase
Published on 09/07/2026 at 07:00, 14 minutes ago

Nouvelle hausse du résultat au premier semestre 2026
Published on 09/07/2026 at 07:00, 14 minutes ago

R&S Group announces changes in the Executive Committee
Published on 09/07/2026 at 07:00, 14 minutes ago

AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network significantly improves profitability in the first half of 2026

Les Echos

Published on 09/04/2026 at 18:57, 2 days 12 hours ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 2 days 12 hours ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 2 days 12 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 12 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 12 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026

View all LES ECHOS COMFI WIRE